Overview

A Study to Compare Safety and Efficacy of Prograf + Myfortic and Advagraf + Myfortic in Liver Transplantation Patients

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
To compare the safety and efficacy of Prograf® with Myfortic® to Advagraf® extended release tacrolimus with Myfortic® in de novo liver transplant recipients.
Phase:
Phase 4
Details
Lead Sponsor:
Astellas Pharma Inc
Collaborator:
Astellas Pharma Taiwan, Inc.
Treatments:
Mycophenolate mofetil
Mycophenolic Acid
Tacrolimus